On December 18, 2023, Youcare Pharmaceutical Group (688658.SH) announced that it held the 17th meeting of the second Board of Directors and the 15th meeting of the second Supervisory Board on December 18, 2024. The meetings approved the proposal to permanently supplement working capital using the remaining overraised funds. The company agreed to use the remaining overraised funds of 38.4278 million RMB (including interest and cash management income, with the specific amount based on the actual amount at the time of transfer) to permanently supplement working capital, which constitutes 7.50% of the total amount of the overraised funds. After using the remaining overraised funds to permanently supplement working capital, the company will have exhausted all overraised funds and will cancel the related special account for raised funds as required.